CAMKIIγ is a targetable driver of multiple myeloma through CaMKIIγ/ Stat3 axis

Demystifying the Druggability of the MYC Family of Oncogenes

Human GM-CSF Recombinant Protein (300-03-1MG)

Frontiers Deregulated calcium signaling in blood cancer

IJMS, Free Full-Text

Frontiers Strategies to target the cancer driver MYC in tumor cells

Modulating Plaque Inflammation via Targeted mRNA Nanoparticles for

Recent advances in targeting the “undruggable” proteins: from drug

CaMKII Gamma antibody (12666-2-AP)

Cells, Free Full-Text

Berbamine suppresses the growth of gastric cancer cells

Full article: Berbamine Suppresses the Growth of Gastric Cancer

CAMKIIγ is a targetable driver of multiple myeloma through CaMKIIγ

Ying Xu's research works Zhejiang Medical University, Hangzhou

4-Chlorobenzoyl berbamine, a novel berbamine derivative, induces

Stabilization of the c-Myc Protein by CAMKIIγ Promotes T Cell